Baxter beats estimates as revenue rises, shares jump 6%
Baxter International Inc. reported first-quarter earnings that surpassed analyst expectations, with adjusted EPS of $0.36 and revenue of $2.7 billion, leading to a 6.4% rise in shares during premarket trading. The company reaffirmed its 2026 full-year earnings guidance of $1.85 to $2.05 per share, which remains above analyst consensus. CEO Andrew Hider noted progress in stabilizing the business while acknowledging ongoing operational challenges and the need for further improvement.
Opening excerpt (first ~120 words) tap to expand
DEERFIELD, Ill. - Baxter International Inc. (NYSE:BAX) reported first-quarter results that exceeded analyst expectations, sending shares up 6.4% in premarket trading Thursday as both earnings and guidance topped forecasts. The medical technology company posted adjusted earnings per share of $0.36, beating the analyst consensus of $0.32 by $0.04. Revenue reached $2.7 billion, surpassing the $2.62 billion estimate and representing a 3% increase on a reported basis, though declining 1% on an organic basis. The company reported a GAAP loss from continuing operations of -$0.03 per share.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Investing.com — News.